User profiles for John R. Hurst
 | JR HurstUCL Verified email at ucl.ac.uk Cited by 26824 |
'Long-COVID': a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19
Large numbers of people are being discharged from hospital following COVID-19 without
assessment of recovery. In 384 patients (mean age 59.9 years; 62% male) followed a median …
assessment of recovery. In 384 patients (mean age 59.9 years; 62% male) followed a median …
Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease
JR Hurst, GC Donaldson, WR Perera… - American journal of …, 2006 - atsjournals.org
Impact: This study explores the use of measuring plasma biomarkers at exacerbation of
chronic obstructive pulmonary disease (COPD), providing insight into the underlying …
chronic obstructive pulmonary disease (COPD), providing insight into the underlying …
[HTML][HTML] Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: a rapid systematic review and meta-analysis
Background Coronavirus disease 2019 (COVID-19) is an evolving infectious disease that
dramatically spread all over the world in the early part of 2020. No studies have yet …
dramatically spread all over the world in the early part of 2020. No studies have yet …
Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease
Treatment of chronic obstructive pulmonary disease (COPD) exacerbations improves
outcomes; however, responses to treatment are variable, and patients with COPD often delay …
outcomes; however, responses to treatment are variable, and patients with COPD often delay …
Airway and systemic inflammation and decline in lung function in patients with COPD
Study objectives Patients with COPD experience lower airway and systemic inflammation,
and an accelerated decline in FEV 1 . There is no evidence on whether this inflammation …
and an accelerated decline in FEV 1 . There is no evidence on whether this inflammation …
Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations
Rationale: Frequent chronic obstructive pulmonary disease (COPD) exacerbations are a
major cause of hospital admission and mortality and are associated with increased airway …
major cause of hospital admission and mortality and are associated with increased airway …
Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease
JR Hurst, WR Perera, TMA Wilkinson… - American journal of …, 2006 - atsjournals.org
Rationale: In addition to pulmonary involvement, stable chronic obstructive pulmonary disease
(COPD) is associated with nasal and systemic inflammation. Although exacerbations of …
(COPD) is associated with nasal and systemic inflammation. Although exacerbations of …
[HTML][HTML] British Thoracic Society Guideline for bronchiectasis in adults
…, A Harvey, CS Haworth, E Hiscocks, JR Hurst… - Thorax, 2019 - thorax.bmj.com
CT scanning can also aid in identifying an aetiology of bronchiectasis eg Allergic
bronchopulmonary aspergillosis (ABPA), Non-tuberculous mycobacteria (NTM), primary ciliary …
bronchopulmonary aspergillosis (ABPA), Non-tuberculous mycobacteria (NTM), primary ciliary …
Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD
TMA Wilkinson, JR Hurst, WR Perera, M Wilks… - Chest, 2006 - Elsevier
Study objectives The inflammatory responses and associated clinical severity of COPD
exacerbations are greatly variable, and the determinants of these factors are poorly understood. …
exacerbations are greatly variable, and the determinants of these factors are poorly understood. …
[HTML][HTML] Susceptibility to exacerbation in COPD
We welcome the report by the SPIROMICS investigators in The Lancet Respiratory Medicine,
1 repeating our 2010 ECLIPSE analysis2 describing exacerbations in chronic obstructive …
1 repeating our 2010 ECLIPSE analysis2 describing exacerbations in chronic obstructive …
